Cited by 120Tuberous Sclerosis Complex ResearchPI3K/AKT/mTOR signaling in cancerGenetics and Neurodevelopmental Disorders

The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.

From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis

Open access

Ehninger, D., De Vries, P. J., Silva, A. J.·2009·Journal of Intellectual Disability Research

DOI 10.1111/j.1365-2788.2009.01208.xPMC PMC2844770

Open this paper in CoChat — free account

Abstract

Background Tuberous sclerosis (TSC) is a multi‐system disorder caused by heterozygous mutations in the TSC1 or TSC2 gene and is often associated with neuropsychiatric symptoms, including intellectual disability, specific neuropsychological deficits, autism, other behavioural disorders and epilepsy. Method Here, we review evidence from animal models of TSC for the role of specific molecular and cellular processes in the pathogenesis of cognitive, developmental and epilepsy‐related manifestations seen in the disorder. Results Recent evidence shows that, in animal models, disinhibited mTOR (mammalian target of rapamycin) signalling substantially contributes to neuropsychiatric phenotypes, including cognitive deficits and seizures. We discuss potential pathogenetic mechanisms involved in the cognitive phenotypes of TSC and present implications regarding mTOR inhibitor‐based treatments for TSC‐related neuropsychiatric features. Conclusions Results suggest that reversing the underlying molecular deficits of TSC with rapamycin or other mTOR inhibitors could result in clinically significant improvements of cognitive function and neurological symptoms, even if treatments are started in adulthood.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2788.2009.01208.x

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
The Tuberous Sclerosis Complex
Crino, P. B., Nathanson, K. L., & Henske, E. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055323 · Cited by 1,793
Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
Slegtenhorst, M. V., Hoogt, R. D., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., Ouweland, A. V. D., Halley, D., Young, J., et al. (1997) · Science · doi:10.1126/science.277.5327.805 · Cited by 1,648
Identification and characterization of the tuberous sclerosis gene on chromosome 16
(1993) · Cell · doi:10.1016/0092-8674(93)90618-z · Cited by 1,645
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
Epidemiological Surveys of Autism and Other Pervasive Developmental Disorders: An Update
Fombonne, E. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1025054610557 · Cited by 1,505
K+ channel regulation of signal propagation in dendrites of hippocampal pyramidal neurons
Hoffman, D. A., Magee, J. C., Colbert, C. M., & Johnston, D. (1997) · Nature · doi:10.1038/43119 · Cited by 1,392

Show all 108 references

Sorted by citations

Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020
Mutations causing syndromic autism define an axis of synaptic pathophysiology
Auerbach, B. D., Osterweil, E. K., & Bear, M. F. (2011) · Nature · doi:10.1038/nature10658 · Cited by 592
Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication
Bozdagi, O., Sakurai, T., Papapetrou, D., Wang, X., Dickstein, D. L., Takahashi, N., Kajiwara, Y., Yang, M., Katz, A. M., Scattoni, M. L., et al. (2010) · Molecular Autism · doi:10.1186/2040-2392-1-15 · Cited by 584
Neurological and neuropsychiatric aspects of tuberous sclerosis complex
Curatolo, P., Moavero, R., & de Vries, P. J. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00069-1 · Cited by 600
Tuberous Sclerosis Associated Neuropsychiatric Disorders (TAND) and the TAND Checklist
de Vries, P. J., Whittemore, V. H., Leclezio, L., Byars, A. W., Dunn, D., Ess, K. C., Hook, D., King, B. H., Sahin, M., & Jansen, A. (2015) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2014.10.004 · Cited by 371
The mTOR signalling cascade: paving new roads to cure neurological disease
Crino, P. B. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.81 · Cited by 368
PI3-kinase/Akt/mTOR signaling: Impaired on/off switches in aging, cognitive decline and Alzheimer's disease
Neill, C. O. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.02.025 · Cited by 300
Toward Fulfilling the Promise of Molecular Medicine in Fragile X Syndrome
Krueger, D. D., & Bear, M. F. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-061109-134644 · Cited by 259
Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics
Uzunova, G., Pallanti, S., & Hollander, E. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1085597 · Cited by 257
The role of mTOR signaling in Alzheimer disease
Oddo, S. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s310 · Cited by 243
An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy
Millan, M. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.015 · Cited by 229
Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders
Ehninger, D., & Silva, A. J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.10.002 · Cited by 223
Self-citation
Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses
Won, H., Mah, W., & Kim, E. (2013) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00019 · Cited by 217
Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops
Mullins, C., Fishell, G., & Tsien, R. W. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.017 · Cited by 167
TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study
de Vries, P. J., Belousova, E., Benedik, M. P., Carter, T., Cottin, V., Curatolo, P., Dahlin, M. G., D’Amato, L., d’Augères, G. B., Ferreira, J. C., et al. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0901-8 · Cited by 190
The Interaction between Early Life Epilepsy and Autistic-Like Behavioral Consequences: A Role for the Mammalian Target of Rapamycin (mTOR) Pathway
Talos, D. M., Sun, H., Zhou, X., Fitzgerald, E. C., Jackson, M. C., Klein, P., Lan, V. J., Joseph, A., & Jensen, F. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035885 · Cited by 182
Role of mTOR Complexes in Neurogenesis
Licausi, F., & Hartman, N. W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051544 · Cited by 172
mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis
Citraro, R., Leo, A., Constanti, A., Russo, E., & Sarro, G. D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.039 · Cited by 165
The genetics of child psychiatric disorders: focus on autism and Tourette syndrome
State, M. W. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.004 · Cited by 162
Behavioral profiles of mouse models for autism spectrum disorders
Ey, E., Leblond, C. S., & Bourgeron, T. (2011) · Autism Research · doi:10.1002/aur.175 · Cited by 166
Finding a better drug for epilepsy: The mTOR pathway as an antiepileptogenic target
Galanopoulou, A. S., Gorter, J. A., & Cepeda, C. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03506.x · Cited by 158
Role for mTOR Signaling and Neuronal Activity in Morphine-Induced Adaptations in Ventral Tegmental Area Dopamine Neurons
Mazei‐Robison, M. S., Koo, J. W., Friedman, A. K., Lansink, C. S., Robison, A. J., Vinish, M., Krishnan, V., Kim, S., Siuta, M., Galli, A., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.10.012 · Cited by 148
Ursolic acid improves high fat diet-induced cognitive impairments by blocking endoplasmic reticulum stress and IκB kinase β/nuclear factor-κB-mediated inflammatory pathways in mice
Lu, J. L., Wu, D., Zheng, Y., Hu, B., Cheng, W., Zhang, Z.-F., & Shan, Q. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.06.009 · Cited by 141
Estradiol-induced object recognition memory consolidation is dependent on activation of mTOR signaling in the dorsal hippocampusPreprint
Fortress, A. M., Fan, L., Orr, P. T., Zhao, Z., & Frick, K. M. (2013) · Learning & Memory · doi:10.1101/lm.026732.112 · Cited by 148
A pulse rapamycin therapy for infantile spasms and associated cognitive decline
Raffo, E., Coppola, A., Ono, T., Briggs, S. W., & Galanopoulou, A. S. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.03.021 · Cited by 140
Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications
Gottfried, O. N., Viskochil, D. H., & Couldwell, W. T. (2009) · Neurosurgical FOCUS · doi:10.3171/2009.11.focus09221 · Cited by 139
Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease
O’Neill, C., Kiely, A. P., Coakley, M. F., Manning, S., & Long-Smith, C. M. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120080 · Cited by 140
Targeting the mTOR Signaling Network for Alzheimer’s Disease Therapy
Wang, C., Yu, J., Miao, D., Wu, Z., Tan, M., & Tan, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8505-8 · Cited by 136
Loss of mTOR repressors Tsc1 or Pten has divergent effects on excitatory and inhibitory synaptic transmission in single hippocampal neuron cultures
Weston, M. C., Chen, H., & Swann, J. W. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00001 · Cited by 123
TOR on the brain
Garelick, M. G., & Kennedy, B. K. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.08.030 · Cited by 120
Reciprocal signaling between translational control pathways and synaptic proteins in autism spectrum disorders
Santini, E., & Klann, E. (2014) · Science Signaling · doi:10.1126/scisignal.2005832 · Cited by 118
Selective Abrogation of BiP/GRP78 Blunts Activation of NF-κB through the ATF6 Branch of the UPR: Involvement of C/EBPβ and mTOR-Dependent Dephosphorylation of Akt
Nakajima, S., Hiramatsu, N., Hayakawa, K., Saito, Y., Kato, H., Huang, T., Yao, J. Q., Paton, A. W., Paton, J. C., & Kitamura, M. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00939-10 · Cited by 117
Targeted Treatments for Cognitive and Neurodevelopmental Disorders in Tuberous Sclerosis Complex
de Vries, P. J. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.001 · Cited by 110
The Essential Role of Soluble Aβ Oligomers in Alzheimer’s Disease
Wang, Z.-X., Tan, L., Liu, J., & Yu, J.-T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9143-0 · Cited by 110
Sensitive time-windows for susceptibility in neurodevelopmental disorders
Meredith, R. M., Dawitz, J., & Kramvis, I. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.03.005 · Cited by 109
Genetic basis of autism: is there a way forward?
Eapen, V. (2011) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328345927e · Cited by 102
Deregulated mTOR-mediated translation in intellectual disability
Troca-Marín, J. A., Alves-Sampaio, A., & Montesinos, M. L. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.01.005 · Cited by 109
The mTOR Signaling Pathway in the Brain: Focus on Epilepsy and Epileptogenesis
Russo, E., Citraro, R., Constanti, A., & Sarro, G. D. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8314-5 · Cited by 91
Cytoarchitectural alterations are widespread in cerebral cortex in tuberous sclerosis complex
Marcotte, L. M., Aronica, E., Baybis, M., & Crino, P. B. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0950-3 · Cited by 86
Autism Spectrum Disorders in Tuberous Sclerosis: Pathogenetic Pathways and Implications for Treatment
Curatolo, P., Napolioni, V., & Moavero, R. (2010) · Journal of Child Neurology · doi:10.1177/0883073810361789 · Cited by 84
Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis
Franz, D. N. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.11.93 · Cited by 78
Neurobiology of autism gene products: towards pathogenesis and drug targets
Kleijer, K. T. E., Schmeißer, M. J., Krueger‐Burg, D., Boeckers, T. M., Scheiffele, P., Bourgeron, T., Brose, N., & Burbach, J. P. H. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3403-3 · Cited by 80
From genes to cognition in tuberous sclerosis: Implications for mTOR inhibitor-based treatment approaches
Ehninger, D. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.015 · Cited by 68
Self-citation
Multifarious roles of mTOR signaling in cognitive aging and cerebrovascular dysfunction of Alzheimer's disease
Uddin, M. S., Rahman, M. A., Kabir, M. T., Behl, T., Mathew, B., Perveen, A., Barreto, G. E., Bin-Jumah, M. N., Abdel‐Daim, M. M., & Ashraf, G. M. (2020) · IUBMB Life · doi:10.1002/iub.2324 · Cited by 66
The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer’s disease
Talboom, J. S., Velázquez, R., & Oddo, S. (2015) · npj Aging and Mechanisms of Disease · doi:10.1038/npjamd.2015.8 · Cited by 67
Emerging Treatments in the Management of Tuberous Sclerosis Complex
Kohrman, M. H. (2012) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2012.02.015 · Cited by 66
Molecular Therapies for Tuberous Sclerosis and Neurofibromatosis
Franz, D. N., & Weiss, B. D. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0269-4 · Cited by 58
Genome-wide analysis of H4K5 acetylation associated with fear memory in mice
Park, C., Rehrauer, H., & Mansuy, I. M. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-539 · Cited by 58
Emerging Pharmacotherapies for Neurodevelopmental Disorders
Wetmore, D. Z., & Garner, C. C. (2010) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3181ee3833 · Cited by 56
Sex differences in cerebellar synaptic transmission and sex-specific responses to autism-linked Gabrb3 mutations in mice
Mercer, A. A., Mayoral-Palarz, K., Tabatadze, N., Woolley, C. S., & Raman, I. M. (2016) · eLife · doi:10.7554/elife.07596 · Cited by 49
Structural and molecular correlates of cognitive aging in the rat
Mota, C., Taipa, R. J. F., das Neves, S. P., Monteiro-Martins, S., Monteiro, S., Palha, J. A., Sousa, N., Sousa, J. C., & Cerqueira, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-39645-w · Cited by 48
Diffusion Tensor Imaging of Commissural and Projection White Matter in Tuberous Sclerosis Complex and Correlation with Tuber Load
Simão, G. N., Raybaud, C., Chuang, S. H., Go, C., Snead, O. C., & Widjaja, E. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2033 · Cited by 45
A Comprehensive Small Interfering RNA Screen Identifies Signaling Pathways Required for Gephyrin Clustering
Wuchter, J., Beuter, S., Treindl, F., Herrmann, T., Zeck, G. M., Templin, M. F., & Volkmer, H. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1261-12.2012 · Cited by 45
mTOR inhibitor reverses autistic-like social deficit behaviours in adult rats with both Tsc2 haploinsufficiency and developmental status epilepticus
Schneider, M., de Vries, P. J., Schönig, K., Roessner, V., & Waltereit, R. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0703-8 · Cited by 44
Rapamycin as an alternative to surgical treatment of subependymal giant cell astrocytomas in a patient with tuberous sclerosis complex
Birca, A., Mercier, C., & Major, P. (2010) · Journal of Neurosurgery Pediatrics · doi:10.3171/2010.7.peds10221 · Cited by 41
Activation of mTOR signaling mediates the increased expression of AChE in high glucose condition: in vitro and in vivo evidences
Liu, Y., Zhang, L., Li, Y., Cheng, Y., Zhu, X., Zhang, F., & Yin, X. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9425-6 · Cited by 41
Sweet Taste Receptor Signaling Network: Possible Implication for Cognitive Functioning
Welcome, M. O., Mastorakis, N. E., & Pereverzev, V. A. (2015) · Neurology Research International · doi:10.1155/2015/606479 · Cited by 39
Primary Cilia as a Possible Link between Left-Right Asymmetry and Neurodevelopmental Diseases
Trulioff, A. S., Ermakov, A. S., & Malashichev, Y. B. (2017) · Genes · doi:10.3390/genes8020048 · Cited by 41
Multiple components of eIF4F are required for protein synthesis-dependent hippocampal long-term potentiation
Hoeffer, C. A., Santini, E., Ma, T., Arnold, E. C., Whelan, A., Wong, H., Pierre, P., Pelletier, J., & Klann, E. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00342.2012 · Cited by 37
Above genetics: Lessons from cerebral development in autism
Williams, E., & Casanova, M. F. (2011) · Translational Neuroscience · doi:10.2478/s13380-011-0016-3 · Cited by 38
Emerging Concepts in Brain Glucose Metabolic Functions: From Glucose Sensing to How the Sweet Taste of Glucose Regulates Its Own Metabolism in Astrocytes and Neurons
Welcome, M. O., & Mastorakis, N. E. (2018) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8503-0 · Cited by 35
Analysis of a purported SHANK3 mutation in a boy with autism: Clinical impact of rare variant research in neurodevelopmental disabilities
Kolevzon, A. L., Cai, G., Soorya, L. V., Takahashi, N., Grodberg, D., Kajiwara, Y., Willner, J. P., Tryfon, A., & Buxbaum, J. D. (2010) · Brain Research · doi:10.1016/j.brainres.2010.11.005 · Cited by 32
Advances in understanding behavioral phenotypes in neurogenetic syndromes
Harris, J. C. (2010) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30276 · Cited by 31
Inhibition of protein translation by the DISC1-Boymaw fusion gene from a Scottish family with major psychiatric disorders
Ji, B., Higa, K. K., Kim, M., Zhou, L., Young, J. W., Geyer, M. A., & Zhou, X. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu285 · Cited by 32
Epilepsy in four genetically determined syndromes of intellectual disability
Leung, H. T. T., & RING, H. A. (2011) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2011.01505.x · Cited by 31
Psychiatric Comorbidity and Treatment Response in Patients with Tuberous Sclerosis Complex
Chung, T. K., Lynch, E. R., Fiser, C. J., Nelson, D. A., Agricola, K. D., Tudor, C., Franz, D. N., & Krueger, D. A. (2011) · Annals of Clinical Psychiatry · doi:10.1177/104012371102300405 · Cited by 30
Chronic administration of theobromine inhibits mTOR signal in rats
Sugimoto, N., Katakura, M., Matsuzaki, K., Sumiyoshi, E., Yachie, A., & Shido, O. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13175 · Cited by 26
Mitochondrial deficiency: a double-edged sword for aging and neurodegeneration
Troulinaki, K., & Bano, D. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00244 · Cited by 24
A brain proteomic investigation of rapamycin effects in the Tsc1 +/− mouse model
Wesseling, H., Elgersma, Y., & Bahn, S. (2017) · Molecular Autism · doi:10.1186/s13229-017-0151-y · Cited by 24
The Small GTPase Rheb Affects Central Brain Neuronal Morphology and Memory Formation in Drosophila
Brown, H. L. D., Kaun, K. R., & Edgar, B. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044888 · Cited by 24
Chronic Binge Alcohol Exposure During Pregnancy Alters mTOR System in Rat Fetal Hippocampus
Lee, J., Lunde-Young, R., Naik, V. D., Ramirez, J. I., Orzabal, M. R., & Ramadoss, J. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14348 · Cited by 19
Beyond Protein Synthesis; The Multifaceted Roles of Tuberin in Cell Cycle Regulation
da Silva, E. F., Fong, J., Roye‐Azar, A., Nadi, A., Drouillard, C., Pillon, A., & Porter, L. A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.806521 · Cited by 17
Hypoxia-inducible factor 1a is a Tsc1-regulated survival factor in newborn neurons in tuberous sclerosis complex
Feliciano, D. M., Zhang, S., Quon, J. L., & Bordey, A. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt018 · Cited by 16
Nursing Implications for the Lifelong Management of Tuberous Sclerosis Complex
Agricola, K. D., Tudor, C., Krueger, D. A., & Franz, D. N. (2013) · Journal of Neuroscience Nursing · doi:10.1097/jnn.0b013e3182986146 · Cited by 15
N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy
Tallarico, M., Leo, A., Guarnieri, L., Zito, M. C., Caro, C. D., Nicoletti, F., Russo, E., Constanti, A., Sarro, G. D., & Citraro, R. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02720-3 · Cited by 16
miRNAs and isomiRs: Serum-Based Biomarkers for the Development of Intellectual Disability and Autism Spectrum Disorder in Tuberous Sclerosis Complex
Scheper, M., Romagnolo, A., Besharat, Z. M., Iyer, A. M., Moavero, R., Hertzberg, C., Weschke, B., Riney, K., Feucht, M., Scholl, T. O., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10081838 · Cited by 15
Everolimus improves behavioral deficits in a patient with autism associated with tuberous sclerosis: a case report
Ishii, R., Wataya‐Kaneda, M., Canuet, L., Nonomura, N., Nakai, Y., & Takeda, M. (2015) · Neuropsychiatric Electrophysiology · doi:10.1186/s40810-015-0004-x · Cited by 13
mTOR Signaling in Epilepsy and Epileptogenesis
Leo, A., Constanti, A., Coppola, A., Citraro, R., Sarro, G. D., & Russo, E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802733-2.00006-2 · Cited by 11
In search for significant cognitive features in Klinefelter syndrome through cross-species comparison of a supernumerary X chromosome
Bruining, H., Swaab, H., de Sonneville, L. M. J., van Rijn, S., van Engeland, H., & Kas, M. J. (2011) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2011.00705.x · Cited by 13
PRAS40 alleviates neurotoxic prion peptide‐induced apoptosis via mTOR‐AKT signaling
Yang, W., Yang, L., Song, Z., Shah, S. Z. A., Cui, Y., Li, C., Zhao, H., Gao, H., Zhou, X., & Zhao, D. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12685 · Cited by 10
Both Maternal and Pup Genotype Influence Ultrasonic Vocalizations and Early Developmental Milestones in Tsc2+/− Mice
Greene-Colozzi, E. A., Sadowski, A. R., Chadwick, E., Tsai, P. T., & Şahin, M. (2014) · Epilepsy Research and Treatment · doi:10.1155/2014/784137 · Cited by 10
Auditory Processing of Speech and Tones in Children With Tuberous Sclerosis Complex
O’Brien, A. M., Bayet, L., Riley, K. D., Nelson, C. A., Şahin, M., & Modi, M. E. (2020) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2020.00014 · Cited by 7
Mice and men show the way
Anagnostou, E. A. (2012) · Nature · doi:10.1038/491196a · Cited by 8
Behavioural Genetics of Childhood Disorders
Freitag, C. M., Asherson, P. J., & Hebebrand, J. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_178 · Cited by 7
A Farnesyltransferase Inhibitor Restores Cognitive Deficits inTsc2+/–Mice through Inhibition of Rheb1
Sugiura, H., Shimada, T., Moriya‐Ito, K., Goto, J.-I., Fujiwara, H., Ishii, R., Shitara, H., Taya, C., Fujii, S., Kobayashi, T., et al. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0449-21.2022 · Cited by 7
Translational Medicine Strategies in Drug Development for Neurodevelopmental Disorders
Srivastava, S., Şahin, M., & Prock, L. A. (2019) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-803161-2.00022-9 · Cited by 6
Education of a Child Neurologist: Developmental Neuroscience Relevant to Child Neurology
Johnston, M. V. (2011) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2011.06.009 · Cited by 6
Importance of tuberin in carcinogenesis
Jin, M., An, Q., & Wang, L. (2017) · Oncology Letters · doi:10.3892/ol.2017.6490 · Cited by 6
Role of Type I Interferon Signaling and Microglia in the Abnormal Long-term Potentiation and Object Place Recognition Deficits of Male Mice With a Mutation of the Tuberous Sclerosis 2 Gene
López‐Aranda, M. F., Boxx, G. M., Phan, M., Bach, K., Mandanas, R., Herrera, I., Taloma, S. E., Thadani, C., Lu, O., Bui, R., et al. (2022) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2022.03.015 · Cited by 5
Self-citation
Lactate Ameliorates Kainic Acid-Induced Neuroinflammation and Cognitive Impairment via the Chemokine Signaling Pathway in Mice
Chu, X., Ge, Y., Geng, C., Cao, P., Wei, P., Fu, B., Deng, Z., Li, Y., & Zhao, G. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s498738 · Cited by 5
New Models for Considering the Role of Medication in the Treatment and Elucidation of the Etiology of Autism
Smile, S., & Anagnostou, E. A. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0326-3 · Cited by 5
Insights into Tuberous Sclerosis Complex : From Genes to Clinics
Kim, S. Y. (2025) · Journal of Korean Neurosurgical Society · doi:10.3340/jkns.2025.0035 · Cited by 4
Sweet-Taste Receptor Signaling Network and Low-Calorie Sweeteners
Welcome, M. O., Mastorakis, N. E., & Pereverzev, V. A. (2016) · Reference series in phytochemistry · doi:10.1007/978-3-319-26478-3_25-1 · Cited by 4
Reduced effect of stimulation of AMPA receptors on cerebral O2 consumption in a rat model of autism
Weiss, H. R., Liu, X., Grewal, P., & CHI, O. Z. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.014 · Cited by 5
Intellectual disabilities and genetic disorders can lead the way in translational research
de Vries, P., & Oliver, C. (2009) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2009.01209.x · Cited by 4
Early Post-Natal Immune Activation Leads to Object Memory Deficits in Female Tsc2+/− Mice: The Importance of Including Both Sexes in Neuroscience Research
López‐Aranda, M. F., Bach, K., Bui, R., Phan, M., Lu, O., Thadani, C., Luchetti, A., Mandanas, R., Herrera, I., López-Ávalos, M. D., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12010203 · Cited by 3
Self-citation
mTOR Signaling in Cortical Network Development
Lin, T. V., & Bordey, A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-415804-7.00015-0 · Cited by 1
Tuberous sclerosis: from gene to targeted therapy
Davies, D. M. (2012) · Clinical Medicine · doi:10.7861/clinmedicine.12-6-s7 · Cited by 1
Phenotypic Variability and mTOR Pathway Gene Aberrations in Familial Tuberous Sclerosis
Sekar, S., Nasser, S., Adkins, J. R., Cuyugan, L., Enriquez, D., Rangasamy, S., Narayanan, V., & Liang, W. S. (2017) · Journal of Pediatric Neurology · doi:10.1055/s-0037-1603349 · Cited by 1
Protocol for EpiCom: A phase 3b/4 study of behavioral outcomes following adjunctive cannabidiol for the management of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)
van Eeghen, A. M., Thiele, E. A., Amin, S., Samanta, D., Jansen, A., Stevens, J., Moore-Ramdin, L., & de Vries, P. J. (2025) · PLoS ONE · doi:10.1371/journal.pone.0324648 · Cited by 1

Authors: Ehninger, D., De Vries, P. J., & Silva, A. J.
Affiliations: University of California, Los Angeles (US)
Corresponding author: Ehninger, D.
ORCID: Ehninger, D.
Silva, A. J.
Venue: Journal of Intellectual Disability Research
Publisher: Wiley
Published: 2009-09-25
Volume: 53
Issue: 10
Pages: 838-851
ISSN: 0964-2633 (ISSN-L)
1365-2788
DOI: 10.1111/j.1365-2788.2009.01208.x
PMC: PMC2844770
OpenAlex: W1981844658
Cited by: 120
References: 108
Citations by year: 2026: 3 · 2025: 4 · 2024: 1 · 2022: 5 · 2020: 3 · 2019: 2 · 2018: 5 · 2017: 6 · 2016: 8 · 2015: 8 · 2014: 9 · 2013: 9 · 2012: 24
FWCI: 2.09
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Journal of Intellectual Disability Research (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Neurological Disorders and Stroke (R01NS038480)
Topics: Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords: tuberous sclerosis complex, mTOR signaling, cognitive impairment, intellectual disability, epilepsy, neuropsychiatric symptoms, TSC1, TSC2, rapamycin, mTOR inhibitors, animal models, autism spectrum disorder, developmental disorders
MeSH terms: Animals, Behavior, Animal, Carrier Proteins, Cognition, Cognition Disorders, Cell Biology, Disease Models, Animal, Epilepsy, Humans, Molecular Biology, Risk Factors, Tuberous Sclerosis, Phosphotransferases (Alcohol Group Acceptor), Mice, Rats, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks